1310459-60-9

Upstream product

• 98-86-2 acetophenone 
• 61018-80-2 (4-hydroxy-1,1-dioxo-1,2-dihydro-1λ⁶-benzo[e][1,2]thiazin-3-yl)-phenyl-methanone 
• 5439-17-8 2-bromo-N-(3-methylphenyl)acetamide 
• 70-11-1 α-bromoacetophenone 
• 128-44-9 saccharin sodium salt 
• 15246-95-4 1,1-dioxo-2-(2-oxo-2-phenyl-ethyl)-1,2-dihydro-1λ⁶-benzo[d]isothiazol-3-one 
• 1310460-32-2 2-(3-benzoyl-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yl)acetic acid 
• 108-44-1 1-amino-3-methylbenzene 
• 919467-55-3 ethyl 2-(3-benzoyl-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yl)acetate 

Relevant academic research and scientific papers

Synthesis and α-glucosidase inhibition activity of 2-[3-(Benzoyl/4-bromobenzoyl)-4-hydroxy-1,1-dioxido-2h-benzo[e][1,2]thiazin-2-yl]-n-arylacetamides: An in silico and biochemical approach

Diabetes mellitus (DM) is a chronic disorder and has affected a large number of people worldwide. Insufficient insulin production causes an increase in blood glucose level that results in DM. To lower the blood glucose level, various drugs are employed th

Identification of cyclicsulfonamide derivatives with an acetamide group as 11β-hydroxysteroid dehydrogenase 1 inhibitors

In the continuation of our 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor research, cyclic sulfonamide derivatives with an acetamide group at the 2-position were synthesized and evaluated for their abilities to inhibit 11β-HSD1. Among this s